Omicron-Specific Booster Vaccine: The Drugs Controller General of India (DCGI) has given emergency use permission for Omicron-specific booster vaccine Gemcovac-OM (GEMCOVAC-OM), developed by Pune-based Gennova Biopharmaceuticals Ltd. The company claimed that Gemkovac-OM is the first booster vaccine against Kovid-19 which has been developed in India against the Omicron variant of Kovid-19. This vaccine has been developed by Genova Biopharmaceuticals in collaboration with the Department of Biotechnology (DBT) under ‘Mission Kovid Suraksha’. It is an mRNA-based vaccine, which has been developed using indigenous platform technology. People who have taken two doses…
Read More